Author
Anderson, Robin | |
Droleskey, Robert - Bob | |
Nisbet, David |
Submitted to: Patent Application
Publication Type: Patent Application Publication Acceptance Date: 6/11/2002 Publication Date: 12/30/2003 Citation: Anderson, R.C., Droleskey, R.E., Nisbet, D.J. 2003. Swainsonine compounds as inhibitors of toxin receptor expression. U.S. Patent 6,670,374B1. Interpretive Summary: Technical Abstract: This invention provides a method for treating infections in animals which are caused by toxin producing enteric bacterial pathogens, including Shigella species, enterohemorrhagic E. coli, and enterotoxigenic E. coli. Receptors expressed by animal cells which typically recognize these bacterial toxins may be modified by administration of swainsonine compounds to the animal, thereby effectively inhibiting toxin binding to the cells. |